NASDAQ: CRDF
Cardiff Oncology Inc Stock Ownership - Who owns Cardiff Oncology?

Insider buying vs selling

Have Cardiff Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mani MohindruCEO2026-07-1434,364$1.46
$50.00kBuy
Gary W. PaceDirector2026-07-14687,285$1.46
$1,000.00kBuy
Mani MohindruChief Executive Officer2026-06-1824,703$1.21
$29.89kBuy
Gary W. PaceDirector2026-06-1830,000$1.22
$36.60kBuy

1 of 1

CRDF insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRDF insiders and whales buy or sell their stock.

CRDF Shareholders

What type of owners hold Cardiff Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Robert Merrill Hunter7.41%5,065,004$4.10MInsider
Blackrock Inc5.82%3,981,387$3.22MInstitution
Gary W. Pace5.61%3,837,098$3.11MInsider
Ra Capital Management LP4.81%3,290,000$2.66MInsider
Bridger Management LLC4.34%2,968,115$2.40MInsider
Vanguard Capital Management LLC4.18%2,855,966$2.31MInstitution
Laurion Capital Management LP3.87%2,646,738$2.14MInstitution
Pfizer Inc3.53%2,411,575$1.95MInstitution
Acorn Capital Advisors LLC2.58%1,762,084$1.43MInstitution
Geode Capital Management LLC2.34%1,599,663$1.30MInstitution

1 of 3

CRDF vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRDF35.96%26.78%Net BuyingNet Buying
BOLD37.78%61.18%Net BuyingNet Buying
PMVP58.61%41.39%Net Selling
IMMP0.18%0.89%
CNTX86.17%1.43%

Cardiff Oncology Stock Ownership FAQ

Who owns Cardiff Oncology?

Cardiff Oncology (NASDAQ: CRDF) is owned by 35.96% institutional shareholders, 26.78% Cardiff Oncology insiders, and 37.26% retail investors. Robert Merrill Hunter is the largest individual Cardiff Oncology shareholder, owning 5.07M shares representing 7.41% of the company. Robert Merrill Hunter's Cardiff Oncology shares are currently valued at $4.31M.

If you're new to stock investing, here's how to buy Cardiff Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.